Vianney Tricou

13PUBLICATIONS
16CO-AUTHORS
Genetically modified animalsAgricultural biotechnology diagnostics (incl. biosensors)Epidemiological methodsInfant and child healthEnvironmental studies in animal production
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 13, 2026
Comment on: Pettersson et al. Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E protein.

Vianney Tricou, Jill Livengood, Mayuri Sharma

|Apr 10, 2025
TAK-003: development of a tetravalent dengue vaccine.

Xavier Sáez-Llorens, Rodrigo DeAntonio, Jenny Guek Hong Low

|Mar 18, 2025
Estimated Efficacy of TAK-003 Against Asymptomatic Dengue Infection in Children and Adolescents Participating in the DEN-301 Trial in Asia Pacific and Latin America.

Tarek El Hindi, Maria Theresa Alera, Lulu Bravo

|Oct 17, 2024
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children.

Sanja Mandaric, Heather Friberg, Xavier Saez-Llorens

|Jul 12, 2024
Immunogenicity, Safety, and Efficacy of a Tetravalent Dengue Vaccine in Children and Adolescents: An Analysis by Age Group.

Charissa Borja-Tabora, LakKumar Fernando, Eduardo Lopez Medina

|Apr 29, 2024
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.

Chukiat Sirivichayakul, Shibadas Biswal, Xavier Saez-Llorens

Pageof 3

Frequent Collaborators

3 joint publications

Shibadas Biswal

2 joint publications

Narcisse Patrice Komas

2 joint publications

Xavier Saez-Llorens

1 joint publications

Eduardo Lopez Medina